Long-term treatment of hyponatremic patients with nephrogenic syndrome of inappropriate antidiuresis: Personal experience and review of published case reports

Nephron - Clinical Practice

Volumn 120, Issue 3, 2012, Pages

  Vandergheynst, F ^a   Brachet, C ^b   Heinrichs, C ^b   Decaux, G ^a  

^a ERASME HOSPITAL   (Belgium)

^b HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

Fluid restriction; Nephrogenic syndrome of inappropriate antidiuresis; Urea; Urine osmolarity

Indexed keywords

ARGIPRESSIN RECEPTOR; DESMOPRESSIN; SATAVAPTAN; SODIUM CHLORIDE; TOLVAPTAN; UREA;

ADULT; AGED; ANTIDIURESIS; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FLUID INTAKE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LONG TERM CARE; MALE; NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; PRIORITY JOURNAL; REVIEW; SODIUM BLOOD LEVEL; WATER DEPRIVATION;

ADULT; AGED; DIURETICS; FUROSEMIDE; GENETIC DISEASES, X-LINKED; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; MALE; OSMOLAR CONCENTRATION; SODIUM CHLORIDE; TIME FACTORS; UREA; WATER; WATER-ELECTROLYTE IMBALANCE; YOUNG ADULT;

EID: 84862490614     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000338539     Document Type: Review

References (20)

1. Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, et al: Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 2005; 352: 1884-1890.
2. Levtchenko EN, Monnens LA: Nephrogenic syndrome of inappropriate antidiuresis. Nephrol Dial Transplant 2010; 25: 2839-2843.
3. Decaux G, Vandergheynst F, Bouko Y, Parma J, Vassart G, Vilain C: Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. J Am Soc Nephrol 2007; 18: 606-612.
4. Ranchin B, Boury-Jamot M, Blanchard G, Dubourg L, Hadj-Aïssa A, Morin D, et al: Familial nephrogenic syndrome of inappropriate antidiuresis: dissociation between aquaporin-2 and vasopressin excretion. J Clin Endocrinol Metab 2010; 95:E37-E43.
5. Vandergheynst F, Pradier O, Beukinga I, Kornreich A, Vassart G, Decaux G: Lack of responsiveness to 1-desamino-D-arginin vasopressin (desmopressin) in male patients with nephrogenic syndrome of inappropriate antidiuresis: from bench to bedside. Eur J Clin Invest 2012; 42: 254-259.
6. Schrier R, Gross P, Gheorghiade M, Berl T, Verbalis J, Czerwiec F: Tolvaptan, a selective oral vasopressin V2-recpetor antagonist, for hyponatremia. N Engl J Med 2006; 16: 2099-2112.
7. Soupart A, Gross P, Legros JJ, Alföldi S, Annane D, Heshmati HM, et al: Successful longterm treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-recpetor antagonist. Clin J Am Soc Nephrol 2006; 1: 1154-1160.
8. Bes DF, Mendilaharzu H, Fenwick RG, Arrizurieta E: Hyponatremia resulting from arginine vasopressin receptor 2 gene mutation. Pediatr Nephrol 2007; 22: 463-466.
9. Marcialis MA, Faa V, Fanos V, Puddu M, Pintus MC, Cao A: Neonatal onset of nephrogenic syndrome of inappropriate antidiuresis. Pediatr Nephrol 2008; 23: 2267-2271.
10. Soule S, Florkowski C, Potter H, Pattison D, Swan M, Hunt P, et al: Intermittent severe, symptomatic hyponatremia due to nephrogenic syndrome of inappropriate antidiuresis. Ann Clin Biochem 2008; 45: 520-523.
11. Gupta S, Cheetham TD, Lambert HJ, Roberts C, Bourn D, et al: Thirst perception and arginine vasopressin production in a kindred with an activating mutation of the type 2 vasopressin receptor: The pathopysiology of nephrogenic syndrome of inappropriate antidiuresis. Eur J Endocrinol 2009; 161: 503-508.
12. Cho YI, Gitelman S, Rosenthal S, Ambler G: Long-term outcomes in a family with nephrogenic syndrome of inappropriate antidiuresis. Int J Pediatr Endocrinol 2009; 2009: 431527.
13. Decaux G, Prospert F, Penninck R, Namias B, Soupart A: 5-year treatment of the chronic syndrome of inappropriate secretion of antidiuretic hormone with oral urea. Nephron 1993; 63: 468-470.
14. Huang E, Feldman B, Schwartz D, Geller D, Rosenthal S, Gitelman S: Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr 2006; 148: 128-131.
15. de Arruda Camargo LA, Saad WA, Cerri PS: Effect of V1 and angiotensin receptorsubtypes of the paraventricular nucleus on the water intake induced by vasopressin in the lateral septal area. Brain Res Bull 2003; 61: 481-487.
16. Robertson G: Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 2006; 119:S36-S42.
17. Zerbe R, Stropes L, Robertson G: Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 1980; 31: 315-327.
18. Decaux G: Treatment of syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron 1983; 85: 82-88.
19. Morin D, Cotte N, Balestre MN, Mouillac B, Manning M, Breton C, et al: The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett 1998; 441: 470-475.
20. Rochdi MD, Vargas GA, Carpentier E, Oligny-Longpré G, Chen S, Kovoor A, et al: Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: Implications for treatments. Mol Pharmacol 2010; 77: 836-845.